Longitudinal serum HIV RNA quantification: Correlation to viral phenotype at seroconversion and clinical outcome

AIDS

Volumn 10, Issue 2, 1996, Pages 167-173

  Katzenstein, Terese L ^a   Pedersen, Court ^b   Nielsen, Claus ^c   Lundgren, Jens D ^d   Jakobsen, Palle H ^a   Gerstoft, Jan ^a  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

HIV; HIV RNA; Seroconversion; Viral load; Viral phenotype

Indexed keywords

CD4 ANTIGEN; DIDANOSINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROCONVERSION; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 0030022017     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199602000-00006     Document Type: Article

References (15)

1. Ho D, Moudgil T, Alam M: Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989, 321:1621-1625.
2. Ferre F, Marchese A, Duffy PC, et al.: Quantitation of HIV viral burden by PCR in HIV seropositive navy personnel representing Walter Reed stages 1 to 6. AIDS Res Hum Retroviruses 1992, 8:869-875.
3. Piatak M, Saag MS, Yang LC, et al.: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993, 259:1749-1754.
4. Nielsen C, Pedersen C, Lundgren JD, Gerstoft J: Biological properties of HIV isolates in primary infection: consequences for the subsequent course of infection. AIDS 1993, 7:1035-1040.
5. Nielsen C, Nielsen CM, Petersen JL, et al.: Isolation of HIV from cultures of purified CD4 lymphocytes. J Virol Methods 1991, 35:15-25.
6. Mackewicz CE, Yang LC, Lifson JD, Levy JA: Non-cytolytic CD8 anti-HIV respones in primary HIV-1 infection. Lancet 1994, 344:1671-1673.
7. Borrow P, Lewicki H, Hahn BH, Shaw CM, Oldstone MB: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994, 68:6103-6110.
8. Koup RA, Safrit JT, Cao C, et al.: Temporal association of cellular immune response with the initial control of HIV viremia in human immunodeficiency virus type 1 syndrome. J Virol 1994, 68:4650-4655.
9. Mellors JW, Kingsley LA, Rinaldi CR, et al.: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995, 122:573-579.
10. Jurriaans S, VanGemen B, Weverling CJ, et al.: The natural history of HIV infection: virus load and virus phenotype independent determinants of clinical course? Virology 1994, 204:223-233.
11. Tzong-Hae L, Sheppard HW, Reis M, Dondero D, Osmond D, Busch MP: Circulation HIV-1 infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. J Acquir Immune Defic Syndr 1994, 7:381-388.
12. Hogervorst E, Jurriaans S, de Wolf F, et al.: Predictors for non-and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24 specific but not V3-specific antibody levels. J Infect Dis 1995, 171:811-821.
13. Ho DD, Neuman AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
14. Pedersen C, Lindhardt BØ, Jensen BL, et al.: Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ 1989, 299:154-157.
15. Keet IPM, Krijnen P, Koot M, et al.: Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993, 7:51-57.